ID
45573
Description
Principal Investigator: Rameen Beroukhim, MD, PhD, Dana-Farber Cancer Institute, Boston, MA 02215, USA MeSH: Meningioma https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000552 Meningiomas are the most common primary brain tumor in the US. Although the tumor suppressor gene NF2 is disrupted in approximately half of meningiomas, the complete spectrum of genetic changes in meningiomas remains poorly understood, particularly in the large subset of tumors without NF2 alterations. Therefore we performed whole-genome sequencing from 11 Grade I meningioma tumor-normal pairs and whole-exome sequencing from an additional 6 tumor-normal pairs to identify somatic mutations, insertions-deletions, copy-number alterations and rearrangements. We validated our results by performing focused sequencing across 48 additional meningiomas.
Link
Keywords
Versions (1)
- 1/24/23 1/24/23 - Dr. Christian Niklas
Copyright Holder
Rameen Beroukhim, MD, PhD, Dana-Farber Cancer Institute, Boston, MA 02215, USA
Uploaded on
January 24, 2023
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
dbGaP phs000552 Genomic Characterization of Meningiomas
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID and consent group of participants with meningioma and involved in the "Genomic Characterization of Meningiomas" project.
- Sample ID, subject ID, and sample use variables obtained from participants with meningioma and involved in the "Genomic Characterization of Meningiomas" project.
- Subject ID, age, and sex of participants with meningioma and involved in the "Genomic Characterization of Meningiomas" project.
- Sample ID, body site where sample was collected, analyte type of samples, tumor status, histological type of samples, and whether the sample was obtained from recurrent tumor associated with participants with meningioma and involved in the "Genomic Characterization of Meningiomas" project.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID and consent group of participants with meningioma and involved in the "Genomic Characterization of Meningiomas" project.
- Sample ID, subject ID, and sample use variables obtained from participants with meningioma and involved in the "Genomic Characterization of Meningiomas" project.
- Subject ID, age, and sex of participants with meningioma and involved in the "Genomic Characterization of Meningiomas" project.
- Sample ID, body site where sample was collected, analyte type of samples, tumor status, histological type of samples, and whether the sample was obtained from recurrent tumor associated with participants with meningioma and involved in the "Genomic Characterization of Meningiomas" project.
C0680251 (UMLS CUI [1,2])
C0428093 (UMLS CUI [1,2])